NCT03756402 (IRRIV-RFR) is a clinical trial in Acute Kidney Injury, sponsored by Ospedale San Bortolo di Vicenza.

Who is sponsoring NCT03756402?

NCT03756402 is sponsored by Ospedale San Bortolo di Vicenza.

What condition does NCT03756402 study?

NCT03756402 studies Acute Kidney Injury.

Is NCT03756402 still recruiting?

NCT03756402 is currently completed. Last updated 29 November 2018.

Last reviewed 2018-11-29 · How we verify

NCT03756402: IRRIV-RFR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

External Validation of IRRIV Test Relationship With Renal Functional Reserve

Completed Last updated 29 November 2018

What this trial tests

trial in Acute Kidney Injury in 47 participants. Completed in 10 January 2016.

Timeline

2 September 2015

Primary endpoint
30 November 2015

10 January 2016

Quick facts

Lead sponsor	Ospedale San Bortolo di Vicenza
Status	Completed
Study type	OBSERVATIONAL
Enrollment	47
Start date	2 September 2015
Primary completion	30 November 2015
Estimated completion	10 January 2016

Conditions studied

Acute Kidney Injury — all drugs for Acute Kidney Injury →

Sponsor

Ospedale San Bortolo di Vicenza

Who can join

18 and older, any sex, with Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The assessment of renal functional reserve (RFR) has been proposed for the risk stratification of patients undergoing potentially nephrotoxic procedures. The investigators hypothesized that there is a correlation between IRRIV and RFR under normal conditions. For this purpose, externally validation of IRRIV test is performed in a validation cohort of healthy subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

NCT07273838 — Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome · Phase 2 · recruiting
NCT07262320 — Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America · recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07215702 — A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kid · Phase 2 · recruiting
NCT06654193 — Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury · Phase 1, PHASE2 · recruiting

Other Ospedale San Bortolo di Vicenza trials

Trials by the same sponsor.

NCT03756376 — The Relationship Between IRRIV and RFR Under Pathologic Conditions · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03756402 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ospedale San Bortolo di Vicenza
Last refreshed: 29 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03756402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing